Share Print
View all Platelet Aggregation

Platelet Aggregation

Bio/Data Corporation is a global leader in the development, design, and manufacture of light transmission aggregometers, the gold standard for platelet function testing. We also develop, manufacture, and provide all required reagents, software and consumables associated with routine as well as user defined testing.

We provide laboratories with the precision instruments, reagents, and consumables to perform comprehensive platelet function testing in the repeatable and consistent manner required to generate accurate results for clinical, therapeutic, and research use. Our instruments and optimized reagents reduce assay variability and produce accurate results for patients, clinicians, and researchers.

Aggregation test results provide a vital insight into platelet pathophysiology enabling medical professionals to monitor platelet function, to conduct special test procedures for heparin induced thrombocytopenia (HIT) and ristocetin induced platelet aggregation (RIPA), and to diagnose various stages of abnormal platelet function and hemostasis disorders, including Sticky Platelet Syndrome, von Willebrand Disease, and Glanzmann’s Disease, or to monitor the use of anti-platelet drugs like Plavix and aspirin.

Bio/Data Corporation has also developed a first in class Light Transmission Aggregometer (LTA) Performance Verification Test System. Our LTA performance monitoring system is a new way to monitor aggregometer function and provide instrument system quality control.

Please refer to our Quality Systems and Standards for more information on how we ensure that our products meet the most stringent standards.

Quick Facts

    • Screen at-risk pre-surgical patients to determine the probability of excessive bleeding during an invasive procedure.
    • Identify and diagnose platelet dysfunction in those with genetic or acquired bleeding disorders.
    • Monitor anti-platelet therapy given to select patients after a stroke or heart attack to help inhibit blood clotting.
    • Detect aspirin resistance in patients who have had a cardiovascular incident.
    • Monitor platelet function during cardiopulmonary bypass surgery, cardiac catherization, and LVAD use.